Over deze podcast
Unravel the business of science with BioSpace. We dive into biopharma's top stories and biggest challenges, whether it’s layoffs, pipeline shake-ups, acquisitions, new FDA approvals or how to regulate AI in drug development.
262 afleveringen · science
BioSpace
Over deze podcast
Unravel the business of science with BioSpace. We dive into biopharma's top stories and biggest challenges, whether it’s layoffs, pipeline shake-ups, acquisitions, new FDA approvals or how to regulate AI in drug development.
Nieuwste afleveringThe supply chain fault lines of modern pharma
Recente afleveringen
- Novo’s canned heart disease trials, Novartis’ clinical fails, first approval for Alexander diseaseeergisteren · 20 min
- Breaking borders: Building biotech scale in Benelux3 sep · 19 min
- Novartis’ and BMS’ paused CAR T trials, RevMed’s pancreatic cancer approval, more MFN deals2 sep · 20 min
- Fragile X at a turning point: Breaking through the clinical bottleneck27 aug · 19 min
- Capricor’s DMD therapy still alive, Merck/Moderna’s cancer vax shines, FDA’s future revealed26 aug · 23 min
- Rewriting the rules of CMV prevention20 aug · 20 min
- Amylyx’s redemption story, Summit’s survival woes, Definium’s anxiety win, more19 aug · 19 min
- The Italian inflection point: Clinical strength, culture and capital13 aug · 19 min
- Replimune finally wins approval, Q2 earnings wrap up, psychedelics stay in spotlight12 aug · 19 min
- Rumors of biggest pharma merger ever drop amid Q2 earnings, contentious FDA adcomms11 aug · 23 min
podlinkr.com/biospace
Voor op een poster of slide.